Price Chart

DATE TIME TYPE PERIOD REPORTED
EPS
ESTIMATED
EPS
SURPRISE
11/12/2021 -- Results Q3 2021 -- -- --
08/13/2021 -- Results Q2 2021 -- -- --
05/17/2021 -- Results Q1 2021 -- -- --
03/31/2021 -- Results Q4 2020 -- -- --
11/16/2020 -- Results Q3 2020 -- -- --
08/14/2020 -- Results Q2 2020 -- -- --
05/14/2020 -- Results Q1 2020 -- -- --
03/30/2020 -- Results Q4 2019 -- -- --
*Estimated Date/Time

Earnings

Next Report Date --
EPS Estimate Upgrade
Last Actual EPS Upgrade
 
4.00
2.00
1.00
 
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
No data available
Last Report Date 11/12/2021
Beat/Miss Upgrade
Return Since -31.36%
Last FQE 09/30/2022
Next FQE 12/30/2022

Profile

Edit
AgeX Therapeutics Inc is a biotechnology company engaged in the development and commercialization of novel therapeutics targeting human aging. The firm through its PureStem and induced Tissue Regeneration (iTR) technologies develop medicines designed to address some of the unsolved problems in aging. Its PureStem derived cell-based therapeutic candidates in development are AGEX-VASC1, AGEX-BAT1 and AGEX-iTR1547.
URL https://www.agexinc.com
Investor Relations URL N/A
HQ State/Province California
Sector Healthcare
Industry Biotechnology
Equity Style Small Cap/Value
Next Earnings Release N/A
Last Earnings Release Nov. 12, 2021
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Dividends

Dividend Per Share (TTM) --
2017
2018
2019
2020
2021
No data available
 
6.00%
4.00%
2.00%
 
Yield to Market 0.00
Yield to Sector 0.00
Yield to Industry 0.00
Last Dividend Amt. --
Dividend Frequency --
Last Ex-Dividend Date --
Yield (TTM) 0%
Forward Yield --
Payout Ratio 0.00%
Cash Payout Ratio 0.00%
Consistent Payer (5Y) No
Consistent Growth (5Y) No

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Total Returns Comparison

Edit comparables

Annual Total Returns Versus Peers

Edit comparables
Loading chart...
Name
2015
2016
2017
2018
2019
2020
2021
YTD
--
--
--
--
-39.13%
-16.48%
-28.29%
-48.99%
1.38%
11.96%
21.83%
-4.38%
31.49%
18.40%
28.71%
-13.17%
-87.17%
63.37%
16.67%
-79.93%
-17.17%
8.91%
-45.97%
-83.84%
-9.04%
-23.93%
70.05%
-17.52%
10.42%
-13.60%
-24.30%
-67.55%
-18.25%
-29.46%
-55.16%
-57.46%
-66.95%
321.7%
-47.71%
-88.34%
56.85%
-66.70%
-33.39%
-96.85%
-9.48%
-24.44%
-28.93%
-73.55%
As of December 01, 2022.

Profile

Edit
AgeX Therapeutics Inc is a biotechnology company engaged in the development and commercialization of novel therapeutics targeting human aging. The firm through its PureStem and induced Tissue Regeneration (iTR) technologies develop medicines designed to address some of the unsolved problems in aging. Its PureStem derived cell-based therapeutic candidates in development are AGEX-VASC1, AGEX-BAT1 and AGEX-iTR1547.
URL https://www.agexinc.com
Investor Relations URL N/A
HQ State/Province California
Sector Healthcare
Industry Biotechnology
Equity Style Small Cap/Value
Next Earnings Release N/A
Last Earnings Release Nov. 12, 2021
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Top Fund Holders

No data available
Symbol Dollars Invested % Weight
     
     
     
     
     
     
     
     
     
     

Top Portfolio Holders

0 of 0

Other Resources

Whale Wisdom 13F Filings
Seeking Alpha Call Transcripts
Nasdaq Insider Trading
Nasdaq Institutional Ownership
Nasdaq Option Chain
SEC SEC Filings
Twitter AGE Tweets